Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 82

1.

Influence of tumour necrosis factor alpha on the outcome of ischaemic postconditioning in the presence of obesity and diabetes.

Lacerda L, Opie LH, Lecour S.

Exp Diabetes Res. 2012;2012:502654. doi: 10.1155/2012/502654.

2.

Ischaemic postconditioning protects against reperfusion injury via the SAFE pathway.

Lacerda L, Somers S, Opie LH, Lecour S.

Cardiovasc Res. 2009 Nov 1;84(2):201-8. doi: 10.1093/cvr/cvp274.

3.

The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion.

Badalzadeh R, Mohammadi M, Najafi M, Ahmadiasl N, Farajnia S, Ebrahimi H.

J Cardiovasc Pharmacol Ther. 2012 Jun;17(2):181-9. doi: 10.1177/1074248411416118.

PMID:
21828282
4.

A potential role for angiotensin II in obesity induced cardiac hypertrophy and ischaemic/reperfusion injury.

du Toit EF, Nabben M, Lochner A.

Basic Res Cardiol. 2005 Jul;100(4):346-54.

PMID:
15821998
6.

Ischaemic preconditioning does not protect the heart in obese and lean animal models of type 2 diabetes.

Kristiansen SB, Løfgren B, Støttrup NB, Khatir D, Nielsen-Kudsk JE, Nielsen TT, Bøtker HE, Flyvbjerg A.

Diabetologia. 2004 Oct;47(10):1716-21.

PMID:
15480537
7.
8.

Mild Type 2 Diabetes Mellitus Reduces the Susceptibility of the Heart to Ischemia/Reperfusion Injury: Identification of Underlying Gene Expression Changes.

Korkmaz-Icöz S, Lehner A, Li S, Vater A, Radovits T, Hegedűs P, Ruppert M, Brlecic P, Zorn M, Karck M, Szabó G.

J Diabetes Res. 2015;2015:396414. doi: 10.1155/2015/396414.

9.

Cytoprotective effects of N,N,N-trimethylsphingosine during ischemia- reperfusion injury are lost in the setting of obesity and diabetes.

Gundewar S, Calvert JW, Elrod JW, Lefer DJ.

Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2462-71.

10.

Anti-inflammatory and cardioprotective effects of tadalafil in diabetic mice.

Varma A, Das A, Hoke NN, Durrant DE, Salloum FN, Kukreja RC.

PLoS One. 2012;7(9):e45243. doi: 10.1371/journal.pone.0045243.

11.
12.

α-Linolenic acid intake attenuates myocardial ischemia/reperfusion injury through anti-inflammatory and anti-oxidative stress effects in diabetic but not normal rats.

Xie N, Zhang W, Li J, Liang H, Zhou H, Duan W, Xu X, Yu S, Zhang H, Yi D.

Arch Med Res. 2011 Apr;42(3):171-81. doi: 10.1016/j.arcmed.2011.04.008.

PMID:
21722811
13.

Ischaemic postconditioning: does cardioplegia influence protection?

Maruyama Y, Chambers DJ.

Eur J Cardiothorac Surg. 2012 Sep;42(3):530-9. doi: 10.1093/ejcts/ezr305.

PMID:
22345279
14.

Ischemic postconditioning protects remodeled myocardium via the PI3K-PKB/Akt reperfusion injury salvage kinase pathway.

Zhu M, Feng J, Lucchinetti E, Fischer G, Xu L, Pedrazzini T, Schaub MC, Zaugg M.

Cardiovasc Res. 2006 Oct 1;72(1):152-62.

16.

Plasma adipokine and inflammatory marker concentrations are altered in obese, as opposed to non-obese, type 2 diabetes patients.

Hansen D, Dendale P, Beelen M, Jonkers RA, Mullens A, Corluy L, Meeusen R, van Loon LJ.

Eur J Appl Physiol. 2010 Jun;109(3):397-404. doi: 10.1007/s00421-010-1362-5.

17.

Streptozotocin diabetes protects against arrhythmias in rat isolated hearts: role of hypothyroidism.

Zhang L, Parratt JR, Beastall GH, Pyne NJ, Furman BL.

Eur J Pharmacol. 2002 Jan 25;435(2-3):269-76.

PMID:
11821037
18.
19.
20.

MG53 participates in ischaemic postconditioning through the RISK signalling pathway.

Zhang Y, Lv F, Jin L, Peng W, Song R, Ma J, Cao CM, Xiao RP.

Cardiovasc Res. 2011 Jul 1;91(1):108-15. doi: 10.1093/cvr/cvr029.

Items per page

Supplemental Content

Support Center